Philipp Kohler

Title: Philipp Kohler: Innovator in Pharmaceutical Chemistry

Introduction

Philipp Kohler is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work is characterized by a focus on innovative solutions to complex medical challenges.

Latest Patents

Kohler holds a patent for "Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan." This invention concerns novel crystalline forms of {5-(4-bromo-phenyl)-6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl}-sulfamide. The patent outlines processes for the preparation of these crystalline forms, pharmaceutical compositions that include them, and their use as endothelin receptor antagonists. Additionally, it discusses new uses of the compound, either alone or in combination with other active ingredients or therapeutic agents. Kohler's patent is a testament to his innovative approach to drug development.

Career Highlights

Philipp Kohler is currently associated with Idorsia Pharmaceuticals Ltd., where he continues to advance his research and development efforts. His work at Idorsia has positioned him as a key player in the pharmaceutical industry, contributing to the development of new therapeutic options for patients.

Collaborations

Kohler has collaborated with esteemed colleagues such as Martin Bolli and Ivan Schindelholz. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in pharmaceutical science.

Conclusion

Philipp Kohler's contributions to pharmaceutical chemistry, particularly through his patent on crystalline forms of a 4-pyrimidinesulfamide derivative, highlight his role as an innovator in the field. His work continues to pave the way for new therapeutic advancements that can significantly impact patient care.